RRN3_HUMAN - dbPTM
RRN3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RRN3_HUMAN
UniProt AC Q9NYV6
Protein Name RNA polymerase I-specific transcription initiation factor RRN3
Gene Name RRN3
Organism Homo sapiens (Human).
Sequence Length 651
Subcellular Localization Nucleus, nucleolus .
Protein Description Required for efficient transcription initiation by RNA polymerase I. Required for the formation of the competent preinitiation complex (PIC). Dissociates from pol I as a consequence of transcription. In vitro, cannot activate transcription in a subsequent transcription reaction (By similarity)..
Protein Sequence MAAPLLHTRLPGDAAASSSAVKKLGASRTGISNMRALENDFFNSPPRKTVRFGGTVTEVLLKYKKGETNDFELLKNQLLDPDIKDDQIINWLLEFRSSIMYLTKDFEQLISIILRLPWLNRSQTVVEEYLAFLGNLVSAQTVFLRPCLSMIASHFVPPRVIIKEGDVDVSDSDDEDDNLPANFDTCHRALQIIARYVPSTPWFLMPILVEKFPFVRKSERTLECYVHNLLRISVYFPTLRHEILELIIEKLLKLDVNASRQGIEDAEETATQTCGGTDSTEGLFNMDEDEETEHETKAGPERLDQMVHPVAERLDILMSLVLSYMKDVCYVDGKVDNGKTKDLYRDLINIFDKLLLPTHASCHVQFFMFYLCSFKLGFAEAFLEHLWKKLQDPSNPAIIRQAAGNYIGSFLARAKFIPLITVKSCLDLLVNWLHIYLNNQDSGTKAFCDVALHGPFYSACQAVFYTFVFRHKQLLSGNLKEGLQYLQSLNFERIVMSQLNPLKICLPSVVNFFAAITNKYQLVFCYTIIERNNRQMLPVIRSTAGGDSVQICTNPLDTFFPFDPCVLKRSKKFIDPIYQVWEDMSAEELQEFKKPMKKDIVEDEDDDFLKGEVPQNDTVIGITPSSFDTHFRSPSSSVGSPPVLYMQPSPL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9MethylationAAPLLHTRLPGDAAA
CCCCCCCCCCCCHHH
28.30115368723
11 (in isoform 3)Phosphorylation-35.0125849741
17PhosphorylationLPGDAAASSSAVKKL
CCCCHHHCHHHHHHH
21.7923401153
18PhosphorylationPGDAAASSSAVKKLG
CCCHHHCHHHHHHHC
20.0029255136
19PhosphorylationGDAAASSSAVKKLGA
CCHHHCHHHHHHHCC
34.2929255136
22AcetylationAASSSAVKKLGASRT
HHCHHHHHHHCCCCC
41.8325953088
22UbiquitinationAASSSAVKKLGASRT
HHCHHHHHHHCCCCC
41.8321906983
22UbiquitinationAASSSAVKKLGASRT
HHCHHHHHHHCCCCC
41.8321906983
29UbiquitinationKKLGASRTGISNMRA
HHHCCCCCCCCHHHH
36.05-
32UbiquitinationGASRTGISNMRALEN
CCCCCCCCHHHHHHC
26.39-
44PhosphorylationLENDFFNSPPRKTVR
HHCCCCCCCCCCEEE
30.9919664994
49PhosphorylationFNSPPRKTVRFGGTV
CCCCCCCEEEECCEE
20.4224732914
55PhosphorylationKTVRFGGTVTEVLLK
CEEEECCEEHHHHHH
25.3228857561
62UbiquitinationTVTEVLLKYKKGETN
EEHHHHHHHHCCCCC
51.3621906983
62UbiquitinationTVTEVLLKYKKGETN
EEHHHHHHHHCCCCC
51.3621906983
65UbiquitinationEVLLKYKKGETNDFE
HHHHHHHCCCCCHHH
59.91-
75UbiquitinationTNDFELLKNQLLDPD
CCHHHHHHHHCCCCC
56.10-
170PhosphorylationKEGDVDVSDSDDEDD
EECCCCCCCCCCCCC
27.2526503892
172PhosphorylationGDVDVSDSDDEDDNL
CCCCCCCCCCCCCCC
39.1825463755
185PhosphorylationNLPANFDTCHRALQI
CCCCCHHHHHHHHHH
13.1820068231
196PhosphorylationALQIIARYVPSTPWF
HHHHHHHHCCCCCCH
14.0020068231
199PhosphorylationIIARYVPSTPWFLMP
HHHHHCCCCCCHHHH
36.7420068231
200PhosphorylationIARYVPSTPWFLMPI
HHHHCCCCCCHHHHH
20.6120068231
233PhosphorylationVHNLLRISVYFPTLR
HHHHHHHHEECHHHH
12.34-
233UbiquitinationVHNLLRISVYFPTLR
HHHHHHHHEECHHHH
12.34-
253UbiquitinationLIIEKLLKLDVNASR
HHHHHHHHCCCCHHH
53.7521906983
253UbiquitinationLIIEKLLKLDVNASR
HHHHHHHHCCCCHHH
53.7521906983
271PhosphorylationEDAEETATQTCGGTD
CCHHHHHCCCCCCCC
31.65-
298UbiquitinationETEHETKAGPERLDQ
CCCCHHCCCHHHHHH
46.3121906983
306SulfoxidationGPERLDQMVHPVAER
CHHHHHHHHHHHHHH
2.7421406390
319PhosphorylationERLDILMSLVLSYMK
HHHHHHHHHHHHHHC
16.3322468782
324PhosphorylationLMSLVLSYMKDVCYV
HHHHHHHHHCCCEEE
12.2022468782
330PhosphorylationSYMKDVCYVDGKVDN
HHHCCCEEECCEECC
11.0422468782
334UbiquitinationDVCYVDGKVDNGKTK
CCEEECCEECCCCCH
41.79-
386UbiquitinationAEAFLEHLWKKLQDP
HHHHHHHHHHHHCCC
5.39-
409PhosphorylationAAGNYIGSFLARAKF
HCHHHHHHHHHHHCC
13.9224719451
415UbiquitinationGSFLARAKFIPLITV
HHHHHHHCCCCCEEH
37.97-
428UbiquitinationTVKSCLDLLVNWLHI
EHHHHHHHHHHHHHH
3.5721906983
480UbiquitinationQLLSGNLKEGLQYLQ
HHHCCCHHHHHHHHH
54.4521906983
568UbiquitinationPFDPCVLKRSKKFID
CCCHHHHHCCHHHCC
33.94-
593UbiquitinationAEELQEFKKPMKKDI
HHHHHHHHCCHHCCC
56.04-
598UbiquitinationEFKKPMKKDIVEDED
HHHCCHHCCCCCCCC
46.57-
610UbiquitinationDEDDDFLKGEVPQND
CCCCCCCCCCCCCCC
53.682190698
618PhosphorylationGEVPQNDTVIGITPS
CCCCCCCCEEEECCH
22.9029255136
623PhosphorylationNDTVIGITPSSFDTH
CCCEEEECCHHHCCC
16.3529255136
625PhosphorylationTVIGITPSSFDTHFR
CEEEECCHHHCCCCC
34.6822210691
626PhosphorylationVIGITPSSFDTHFRS
EEEECCHHHCCCCCC
28.4829255136
629PhosphorylationITPSSFDTHFRSPSS
ECCHHHCCCCCCCCC
22.3926074081
633PhosphorylationSFDTHFRSPSSSVGS
HHCCCCCCCCCCCCC
28.3422115753
635PhosphorylationDTHFRSPSSSVGSPP
CCCCCCCCCCCCCCC
36.1730278072
636PhosphorylationTHFRSPSSSVGSPPV
CCCCCCCCCCCCCCE
32.2125159151
637PhosphorylationHFRSPSSSVGSPPVL
CCCCCCCCCCCCCEE
34.5325159151
640PhosphorylationSPSSSVGSPPVLYMQ
CCCCCCCCCCEEEEC
24.7130278072
645PhosphorylationVGSPPVLYMQPSPL-
CCCCCEEEECCCCC-
8.2423403867
649PhosphorylationPVLYMQPSPL-----
CEEEECCCCC-----
23.1825159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
44SPhosphorylationKinaseCDK2P24941
PSP
170SPhosphorylationKinaseCSNK2A1P68400
GPS
172SPhosphorylationKinaseCSNK2A1P68400
GPS
200TPhosphorylationKinaseMK09P45984
PhosphoELM
633SPhosphorylationKinaseMAPK3P27361
GPS
635SPhosphorylationKinaseAMPKG2Q9UGJ0
PSP
635SPhosphorylationKinasePRKAA1Q13131
GPS
649SPhosphorylationKinaseRPS6KA3P51812
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
200TPhosphorylation

15805466

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RRN3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RPA2_MOUSEPolr1bphysical
15004009
EIF3L_MOUSEEif3lphysical
15004009
RPA1_HUMANPOLR1Aphysical
11250903
TBP_HUMANTBPphysical
11250903
TAF1B_HUMANTAF1Bphysical
11250903
UBF1_HUMANUBTFphysical
11250903
TAF1C_HUMANTAF1Cphysical
11250903
TAF1A_HUMANTAF1Aphysical
11250903
RPA49_HUMANPOLR1Ephysical
19214185
RPA2_MOUSEPolr1bphysical
12393749
TIF1B_MOUSETrim28physical
12393749
RPA2_HUMANPOLR1Bphysical
15558034
ACTS_HUMANACTA1physical
15558034
RPA43_YEASTRPA43physical
23393135
TAF12_YEASTTAF12physical
23393135
MYO1C_HUMANMYO1Cphysical
15558034

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RRN3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-170; SER-172 ANDSER-640, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND MASSSPECTROMETRY.
"The nucleolus as a stress sensor: JNK2 inactivates the transcriptionfactor TIF-IA and down-regulates rRNA synthesis.";
Mayer C., Bierhoff H., Grummt I.;
Genes Dev. 19:933-941(2005).
Cited for: PHOSPHORYLATION AT THR-200 BY MAPK9/JNK2, AND FUNCTION.

TOP